Clinical trial
Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
NCT05527340 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
- Lead sponsor
- PETHEMA Foundation
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- December 15, 2022
- Completion date
- December 31, 2029
- Enrollment
- 140 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.